The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical trial in progress: A study of VB-111 combined with paclitaxel vs. paclitaxel for treatment of recurrent platinum-resistant ovarian cancer (OVAL, VB-111-701/GOG-3018).
 
Richard T. Penson
Honoraria - VBL Therapeutics
Consulting or Advisory Role - VBL Therapeutics
Research Funding - VBL Therapeutics
Travel, Accommodations, Expenses - VBL Therapeutics
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Janssen Oncology (Inst); TESARO (Inst); VBL Therapeutics (Inst)
Research Funding - Lilly (Inst); PTC Therapeutics (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Thomas J. Herzog
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Johnson & Johnson; Roche/Genentech; Tesaro
 
Robert Allen Burger
Honoraria - Expertix
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Gradalis; Immunogen; InVitae; Janssen Research & Development; Merck; Morphotek; Regeneron; Tesaro; VBL Therapeutics
 
Laurence S Freedman
Travel, Accommodations, Expenses - Gamida Cell; VBL Therapeutics
Other Relationship - Gamida Cell; Mediwound; VBL Therapeutics
 
Noa Lowenton-Spier
Employment - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Travel, Accommodations, Expenses - VBL Therapeutics
 
Dror Harats
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
Travel, Accommodations, Expenses - VBL Therapeutics
Other Relationship - VBL Therapeutics
 
Naamit Sher
Employment - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
Travel, Accommodations, Expenses - VBL Therapeutics
 
Yael Chava Cohen
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Honoraria - Amgen; Janssen
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Takeda
Research Funding - Amgen (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
Travel, Accommodations, Expenses - VBL Therapeutics
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)